nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—ABCB1—peripheral nervous system neoplasm	0.452	1	CbGaD
Metoprolol—SLC22A2—Cisplatin—peripheral nervous system neoplasm	0.0764	0.253	CbGbCtD
Metoprolol—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0511	0.169	CbGbCtD
Metoprolol—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0511	0.169	CbGbCtD
Metoprolol—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0354	0.117	CbGbCtD
Metoprolol—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0218	0.0721	CbGbCtD
Metoprolol—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0203	0.0672	CbGbCtD
Metoprolol—ABCB1—Etoposide—peripheral nervous system neoplasm	0.02	0.066	CbGbCtD
Metoprolol—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0136	0.045	CbGbCtD
Metoprolol—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0128	0.0424	CbGbCtD
Metoprolol—Chlorphenesin—BCHE—peripheral nervous system neoplasm	0.00139	0.524	CrCbGaD
Metoprolol—Atenolol—ABCB1—peripheral nervous system neoplasm	0.000546	0.205	CrCbGaD
Metoprolol—Acebutolol—ABCB1—peripheral nervous system neoplasm	0.000504	0.19	CrCbGaD
Metoprolol—Propranolol—ABCB1—peripheral nervous system neoplasm	0.000215	0.0808	CrCbGaD
Metoprolol—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000176	0.000724	CcSEcCtD
Metoprolol—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000176	0.000723	CcSEcCtD
Metoprolol—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000175	0.000722	CcSEcCtD
Metoprolol—Pain—Vincristine—peripheral nervous system neoplasm	0.000175	0.000722	CcSEcCtD
Metoprolol—Constipation—Vincristine—peripheral nervous system neoplasm	0.000175	0.000722	CcSEcCtD
Metoprolol—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000175	0.000722	CcSEcCtD
Metoprolol—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000175	0.00072	CcSEcCtD
Metoprolol—Rash—Melphalan—peripheral nervous system neoplasm	0.000175	0.000719	CcSEcCtD
Metoprolol—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000175	0.000719	CcSEcCtD
Metoprolol—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000174	0.000716	CcSEcCtD
Metoprolol—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000173	0.000713	CcSEcCtD
Metoprolol—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000712	CcSEcCtD
Metoprolol—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000712	CcSEcCtD
Metoprolol—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.00071	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000172	0.000708	CcSEcCtD
Metoprolol—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000705	CcSEcCtD
Metoprolol—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00017	0.000697	CcSEcCtD
Metoprolol—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000169	0.000696	CcSEcCtD
Metoprolol—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000169	0.000696	CcSEcCtD
Metoprolol—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000168	0.000693	CcSEcCtD
Metoprolol—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000168	0.000693	CcSEcCtD
Metoprolol—Nausea—Topotecan—peripheral nervous system neoplasm	0.000168	0.000692	CcSEcCtD
Metoprolol—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000168	0.00069	CcSEcCtD
Metoprolol—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000168	0.000689	CcSEcCtD
Metoprolol—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000167	0.000687	CcSEcCtD
Metoprolol—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000167	0.000687	CcSEcCtD
Metoprolol—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000686	CcSEcCtD
Metoprolol—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000684	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000165	0.00068	CcSEcCtD
Metoprolol—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000165	0.000678	CcSEcCtD
Metoprolol—Nausea—Melphalan—peripheral nervous system neoplasm	0.000165	0.000678	CcSEcCtD
Metoprolol—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000163	0.00067	CcSEcCtD
Metoprolol—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000163	0.00067	CcSEcCtD
Metoprolol—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000162	0.000667	CcSEcCtD
Metoprolol—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000162	0.000667	CcSEcCtD
Metoprolol—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000162	0.000667	CcSEcCtD
Metoprolol—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000666	CcSEcCtD
Metoprolol—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000162	0.000665	CcSEcCtD
Metoprolol—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000161	0.000664	CcSEcCtD
Metoprolol—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000161	0.000661	CcSEcCtD
Metoprolol—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000659	CcSEcCtD
Metoprolol—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000659	CcSEcCtD
Metoprolol—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000657	CcSEcCtD
Metoprolol—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000652	CcSEcCtD
Metoprolol—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000157	0.000646	CcSEcCtD
Metoprolol—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000157	0.000645	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000157	0.000644	CcSEcCtD
Metoprolol—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000155	0.000639	CcSEcCtD
Metoprolol—Pain—Cisplatin—peripheral nervous system neoplasm	0.000155	0.000638	CcSEcCtD
Metoprolol—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000153	0.000629	CcSEcCtD
Metoprolol—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000151	0.000622	CcSEcCtD
Metoprolol—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000151	0.00062	CcSEcCtD
Metoprolol—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000615	CcSEcCtD
Metoprolol—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000149	0.000615	CcSEcCtD
Metoprolol—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000149	0.000614	CcSEcCtD
Metoprolol—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000613	CcSEcCtD
Metoprolol—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000148	0.00061	CcSEcCtD
Metoprolol—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000148	0.000608	CcSEcCtD
Metoprolol—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000608	CcSEcCtD
Metoprolol—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000147	0.000606	CcSEcCtD
Metoprolol—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000604	CcSEcCtD
Metoprolol—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000146	0.000601	CcSEcCtD
Metoprolol—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000146	0.000599	CcSEcCtD
Metoprolol—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000145	0.000596	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000143	0.00059	CcSEcCtD
Metoprolol—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000143	0.00059	CcSEcCtD
Metoprolol—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000143	0.00059	CcSEcCtD
Metoprolol—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000586	CcSEcCtD
Metoprolol—Pain—Etoposide—peripheral nervous system neoplasm	0.000142	0.000585	CcSEcCtD
Metoprolol—Constipation—Etoposide—peripheral nervous system neoplasm	0.000142	0.000585	CcSEcCtD
Metoprolol—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000584	CcSEcCtD
Metoprolol—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000141	0.000579	CcSEcCtD
Metoprolol—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00014	0.000578	CcSEcCtD
Metoprolol—Sweating—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000576	CcSEcCtD
Metoprolol—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000569	CcSEcCtD
Metoprolol—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000568	CcSEcCtD
Metoprolol—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000568	CcSEcCtD
Metoprolol—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000137	0.000563	CcSEcCtD
Metoprolol—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000136	0.000561	CcSEcCtD
Metoprolol—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000561	CcSEcCtD
Metoprolol—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000559	CcSEcCtD
Metoprolol—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000136	0.000559	CcSEcCtD
Metoprolol—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000136	0.000558	CcSEcCtD
Metoprolol—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000135	0.000557	CcSEcCtD
Metoprolol—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000134	0.000552	CcSEcCtD
Metoprolol—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000134	0.000552	CcSEcCtD
Metoprolol—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000134	0.00055	CcSEcCtD
Metoprolol—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000549	CcSEcCtD
Metoprolol—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000133	0.000549	CcSEcCtD
Metoprolol—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000132	0.000543	CcSEcCtD
Metoprolol—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000542	CcSEcCtD
Metoprolol—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000541	CcSEcCtD
Metoprolol—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000131	0.000541	CcSEcCtD
Metoprolol—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000131	0.000541	CcSEcCtD
Metoprolol—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000541	CcSEcCtD
Metoprolol—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000131	0.00054	CcSEcCtD
Metoprolol—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00013	0.000537	CcSEcCtD
Metoprolol—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00013	0.000536	CcSEcCtD
Metoprolol—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000533	CcSEcCtD
Metoprolol—Rash—Vincristine—peripheral nervous system neoplasm	0.000129	0.000532	CcSEcCtD
Metoprolol—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000129	0.000532	CcSEcCtD
Metoprolol—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000531	CcSEcCtD
Metoprolol—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000129	0.00053	CcSEcCtD
Metoprolol—Headache—Vincristine—peripheral nervous system neoplasm	0.000129	0.000529	CcSEcCtD
Metoprolol—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000526	CcSEcCtD
Metoprolol—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000126	0.00052	CcSEcCtD
Metoprolol—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000126	0.00052	CcSEcCtD
Metoprolol—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000519	CcSEcCtD
Metoprolol—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000124	0.000511	CcSEcCtD
Metoprolol—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000508	CcSEcCtD
Metoprolol—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000504	CcSEcCtD
Metoprolol—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000122	0.000504	CcSEcCtD
Metoprolol—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000503	CcSEcCtD
Metoprolol—Nausea—Vincristine—peripheral nervous system neoplasm	0.000122	0.000501	CcSEcCtD
Metoprolol—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000501	CcSEcCtD
Metoprolol—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.0005	CcSEcCtD
Metoprolol—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000499	CcSEcCtD
Metoprolol—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000492	CcSEcCtD
Metoprolol—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000119	0.000491	CcSEcCtD
Metoprolol—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000491	CcSEcCtD
Metoprolol—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000489	CcSEcCtD
Metoprolol—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000487	CcSEcCtD
Metoprolol—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000486	CcSEcCtD
Metoprolol—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000118	0.000484	CcSEcCtD
Metoprolol—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000482	CcSEcCtD
Metoprolol—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000481	CcSEcCtD
Metoprolol—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000477	CcSEcCtD
Metoprolol—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000115	0.000475	CcSEcCtD
Metoprolol—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000473	CcSEcCtD
Metoprolol—Rash—Cisplatin—peripheral nervous system neoplasm	0.000114	0.000471	CcSEcCtD
Metoprolol—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000114	0.00047	CcSEcCtD
Metoprolol—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000114	0.000468	CcSEcCtD
Metoprolol—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000467	CcSEcCtD
Metoprolol—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000465	CcSEcCtD
Metoprolol—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000463	CcSEcCtD
Metoprolol—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000463	CcSEcCtD
Metoprolol—Tension—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000461	CcSEcCtD
Metoprolol—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000112	0.00046	CcSEcCtD
Metoprolol—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000456	CcSEcCtD
Metoprolol—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000453	CcSEcCtD
Metoprolol—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00011	0.000452	CcSEcCtD
Metoprolol—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000452	CcSEcCtD
Metoprolol—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000451	CcSEcCtD
Metoprolol—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.00045	CcSEcCtD
Metoprolol—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000446	CcSEcCtD
Metoprolol—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000108	0.000443	CcSEcCtD
Metoprolol—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000443	CcSEcCtD
Metoprolol—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000441	CcSEcCtD
Metoprolol—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000437	CcSEcCtD
Metoprolol—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000106	0.000435	CcSEcCtD
Metoprolol—Rash—Etoposide—peripheral nervous system neoplasm	0.000105	0.000431	CcSEcCtD
Metoprolol—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000105	0.000431	CcSEcCtD
Metoprolol—Headache—Etoposide—peripheral nervous system neoplasm	0.000104	0.000428	CcSEcCtD
Metoprolol—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000428	CcSEcCtD
Metoprolol—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000426	CcSEcCtD
Metoprolol—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000426	CcSEcCtD
Metoprolol—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000422	CcSEcCtD
Metoprolol—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000422	CcSEcCtD
Metoprolol—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000421	CcSEcCtD
Metoprolol—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000102	0.00042	CcSEcCtD
Metoprolol—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000418	CcSEcCtD
Metoprolol—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000415	CcSEcCtD
Metoprolol—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000413	CcSEcCtD
Metoprolol—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	9.95e-05	0.00041	CcSEcCtD
Metoprolol—Nausea—Etoposide—peripheral nervous system neoplasm	9.87e-05	0.000406	CcSEcCtD
Metoprolol—Hypertension—Epirubicin—peripheral nervous system neoplasm	9.85e-05	0.000405	CcSEcCtD
Metoprolol—Arthralgia—Epirubicin—peripheral nervous system neoplasm	9.72e-05	0.0004	CcSEcCtD
Metoprolol—Chest pain—Epirubicin—peripheral nervous system neoplasm	9.72e-05	0.0004	CcSEcCtD
Metoprolol—Anxiety—Epirubicin—peripheral nervous system neoplasm	9.68e-05	0.000398	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	9.65e-05	0.000397	CcSEcCtD
Metoprolol—Dry mouth—Epirubicin—peripheral nervous system neoplasm	9.5e-05	0.000391	CcSEcCtD
Metoprolol—Vertigo—Doxorubicin—peripheral nervous system neoplasm	9.49e-05	0.00039	CcSEcCtD
Metoprolol—Syncope—Doxorubicin—peripheral nervous system neoplasm	9.47e-05	0.00039	CcSEcCtD
Metoprolol—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	9.45e-05	0.000389	CcSEcCtD
Metoprolol—Confusional state—Epirubicin—peripheral nervous system neoplasm	9.39e-05	0.000386	CcSEcCtD
Metoprolol—Palpitations—Doxorubicin—peripheral nervous system neoplasm	9.33e-05	0.000384	CcSEcCtD
Metoprolol—Oedema—Epirubicin—peripheral nervous system neoplasm	9.32e-05	0.000383	CcSEcCtD
Metoprolol—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	9.28e-05	0.000382	CcSEcCtD
Metoprolol—Shock—Epirubicin—peripheral nervous system neoplasm	9.17e-05	0.000377	CcSEcCtD
Metoprolol—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	9.14e-05	0.000376	CcSEcCtD
Metoprolol—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	9.12e-05	0.000375	CcSEcCtD
Metoprolol—Hypertension—Doxorubicin—peripheral nervous system neoplasm	9.12e-05	0.000375	CcSEcCtD
Metoprolol—Tachycardia—Epirubicin—peripheral nervous system neoplasm	9.09e-05	0.000374	CcSEcCtD
Metoprolol—Skin disorder—Epirubicin—peripheral nervous system neoplasm	9.05e-05	0.000372	CcSEcCtD
Metoprolol—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	9.01e-05	0.000371	CcSEcCtD
Metoprolol—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	8.99e-05	0.00037	CcSEcCtD
Metoprolol—Chest pain—Doxorubicin—peripheral nervous system neoplasm	8.99e-05	0.00037	CcSEcCtD
Metoprolol—Anxiety—Doxorubicin—peripheral nervous system neoplasm	8.96e-05	0.000369	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	8.93e-05	0.000367	CcSEcCtD
Metoprolol—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	8.79e-05	0.000362	CcSEcCtD
Metoprolol—Hypotension—Epirubicin—peripheral nervous system neoplasm	8.71e-05	0.000358	CcSEcCtD
Metoprolol—Confusional state—Doxorubicin—peripheral nervous system neoplasm	8.69e-05	0.000358	CcSEcCtD
Metoprolol—Oedema—Doxorubicin—peripheral nervous system neoplasm	8.62e-05	0.000355	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	8.49e-05	0.000349	CcSEcCtD
Metoprolol—Shock—Doxorubicin—peripheral nervous system neoplasm	8.48e-05	0.000349	CcSEcCtD
Metoprolol—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	8.45e-05	0.000348	CcSEcCtD
Metoprolol—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	8.44e-05	0.000347	CcSEcCtD
Metoprolol—Insomnia—Epirubicin—peripheral nervous system neoplasm	8.43e-05	0.000347	CcSEcCtD
Metoprolol—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	8.41e-05	0.000346	CcSEcCtD
Metoprolol—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	8.37e-05	0.000344	CcSEcCtD
Metoprolol—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	8.37e-05	0.000344	CcSEcCtD
Metoprolol—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	8.33e-05	0.000343	CcSEcCtD
Metoprolol—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	8.31e-05	0.000342	CcSEcCtD
Metoprolol—Somnolence—Epirubicin—peripheral nervous system neoplasm	8.28e-05	0.000341	CcSEcCtD
Metoprolol—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	8.2e-05	0.000337	CcSEcCtD
Metoprolol—Hypotension—Doxorubicin—peripheral nervous system neoplasm	8.05e-05	0.000331	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	8.04e-05	0.000331	CcSEcCtD
Metoprolol—Fatigue—Epirubicin—peripheral nervous system neoplasm	8.03e-05	0.00033	CcSEcCtD
Metoprolol—Pain—Epirubicin—peripheral nervous system neoplasm	7.97e-05	0.000328	CcSEcCtD
Metoprolol—Constipation—Epirubicin—peripheral nervous system neoplasm	7.97e-05	0.000328	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	7.85e-05	0.000323	CcSEcCtD
Metoprolol—Insomnia—Doxorubicin—peripheral nervous system neoplasm	7.8e-05	0.000321	CcSEcCtD
Metoprolol—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	7.74e-05	0.000318	CcSEcCtD
Metoprolol—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	7.68e-05	0.000316	CcSEcCtD
Metoprolol—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	7.68e-05	0.000316	CcSEcCtD
Metoprolol—Somnolence—Doxorubicin—peripheral nervous system neoplasm	7.66e-05	0.000315	CcSEcCtD
Metoprolol—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	7.62e-05	0.000313	CcSEcCtD
Metoprolol—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	7.59e-05	0.000312	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	7.44e-05	0.000306	CcSEcCtD
Metoprolol—Fatigue—Doxorubicin—peripheral nervous system neoplasm	7.43e-05	0.000306	CcSEcCtD
Metoprolol—Urticaria—Epirubicin—peripheral nervous system neoplasm	7.4e-05	0.000305	CcSEcCtD
Metoprolol—Constipation—Doxorubicin—peripheral nervous system neoplasm	7.37e-05	0.000303	CcSEcCtD
Metoprolol—Pain—Doxorubicin—peripheral nervous system neoplasm	7.37e-05	0.000303	CcSEcCtD
Metoprolol—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	7.36e-05	0.000303	CcSEcCtD
Metoprolol—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	7.36e-05	0.000303	CcSEcCtD
Metoprolol—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	7.1e-05	0.000292	CcSEcCtD
Metoprolol—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	7.05e-05	0.00029	CcSEcCtD
Metoprolol—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	6.86e-05	0.000282	CcSEcCtD
Metoprolol—Urticaria—Doxorubicin—peripheral nervous system neoplasm	6.85e-05	0.000282	CcSEcCtD
Metoprolol—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	6.81e-05	0.00028	CcSEcCtD
Metoprolol—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	6.81e-05	0.00028	CcSEcCtD
Metoprolol—Asthenia—Epirubicin—peripheral nervous system neoplasm	6.68e-05	0.000275	CcSEcCtD
Metoprolol—Pruritus—Epirubicin—peripheral nervous system neoplasm	6.59e-05	0.000271	CcSEcCtD
Metoprolol—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	6.37e-05	0.000262	CcSEcCtD
Metoprolol—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	6.35e-05	0.000261	CcSEcCtD
Metoprolol—Asthenia—Doxorubicin—peripheral nervous system neoplasm	6.18e-05	0.000254	CcSEcCtD
Metoprolol—Dizziness—Epirubicin—peripheral nervous system neoplasm	6.16e-05	0.000253	CcSEcCtD
Metoprolol—Pruritus—Doxorubicin—peripheral nervous system neoplasm	6.1e-05	0.000251	CcSEcCtD
Metoprolol—Vomiting—Epirubicin—peripheral nervous system neoplasm	5.92e-05	0.000244	CcSEcCtD
Metoprolol—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	5.9e-05	0.000243	CcSEcCtD
Metoprolol—Rash—Epirubicin—peripheral nervous system neoplasm	5.87e-05	0.000242	CcSEcCtD
Metoprolol—Dermatitis—Epirubicin—peripheral nervous system neoplasm	5.87e-05	0.000241	CcSEcCtD
Metoprolol—Headache—Epirubicin—peripheral nervous system neoplasm	5.84e-05	0.00024	CcSEcCtD
Metoprolol—Dizziness—Doxorubicin—peripheral nervous system neoplasm	5.7e-05	0.000235	CcSEcCtD
Metoprolol—Nausea—Epirubicin—peripheral nervous system neoplasm	5.53e-05	0.000228	CcSEcCtD
Metoprolol—Vomiting—Doxorubicin—peripheral nervous system neoplasm	5.48e-05	0.000226	CcSEcCtD
Metoprolol—Rash—Doxorubicin—peripheral nervous system neoplasm	5.43e-05	0.000224	CcSEcCtD
Metoprolol—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	5.43e-05	0.000223	CcSEcCtD
Metoprolol—Headache—Doxorubicin—peripheral nervous system neoplasm	5.4e-05	0.000222	CcSEcCtD
Metoprolol—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.12e-05	0.000211	CcSEcCtD
